Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Marc DeCongelio

ResearcherPublications, citations & collaboration network

Marc DeCongelio is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 42 works, 49 citations, an h-index of 4 and an i10-index of 1.

42
Works
49
Citations
4
h-index
1
i10-index

How has Marc DeCongelio's publication output changed over time?

ScholarIQpublication output · 2018–2025

Output grew0% over the shown period — from 1 works in 2018 to 1 in 2025.

1
1
3
1
3
1
201820212022202320242025

What are the most-cited papers on Marc DeCongelio?

ScholarIQmost cited works
Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (<scp>POWER</scp>) study
Amy K. Dickey, Kristen Wheeden, Desiree Lyon, Sue Burrell, Sean Hegarty, Rocco Falchetto, Edrin R. Williams, Jasmin Barman‐Aksözen, Marc DeCongelio, Alison Bulkley, Joana Matos, Tarek Mnif, Jordanna Mora, John J. Ko, Stephen Meninger, Stephen Lombardelli, Danielle Nance
JIMD Reports. 202219 CitationsOPEN ACCESS
Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment
Moshe Chaim Ornstein, Lisa Rosenblatt, Xin Yin, Viviana Del Tejo, Sarah Guttenplan, Flavia Ejzykowicz, Kathleen Beusterien, Oliver Will, deMauri Mackie, Grace Skiles, Marc DeCongelio
Patient Preference and Adherence. 20247 CitationsOPEN ACCESS
A global perspective in <scp>second‐line</scp> treatment patterns for patients with advanced esophageal squamous cell carcinoma
Dena H. Jaffe, Joseph Gricar, Marc DeCongelio, deMauri Mackie
Thoracic Cancer. 20225 CitationsOPEN ACCESS
The incidence and prevalence of immunoglobulin A nephropathy in the United States
Marc DeCongelio, Sarah Ali, Martina Furegato, Sandipan Bhattacharjee, Ancilla W. Fernandes
Clinical Nephrology. 20245 CitationsOPEN ACCESS
Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control Data
Ronald D. Perrone, Diana Garbinsky, Sasikiran Nunna, Hema K. Gandhi, Ancilla W. Fernandes, Gabriela Burgos, Abisola Olopoenia, Marc DeCongelio, Martine C. Maculaitis, Xiaolei Zhou
Kidney Medicine. 20254 CitationsOPEN ACCESS

Related on ScholarIQ

Oracle (United States)
Institution
Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (<scp>POWER</scp>) study
Paper
Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment
Paper
A global perspective in <scp>second‐line</scp> treatment patterns for patients with advanced esophageal squamous cell carcinoma
Paper
The incidence and prevalence of immunoglobulin A nephropathy in the United States
Paper
Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control Data
Paper
470M+ articles · free account